GlaxoSmithKline Pharmaceuticals Limited announced at the board meeting held on May 16, 2022 that the company approved appointment of Mr. Manu Anand an Additional Independent Director of the Company for a term of five years with effect From 16th May 2022. Mr. Manu Anand is not related to any of the existing Directors of the Company and he is not debarred from holding the Office of Director by virtue of any order passed by SEBI or any other such authority. In his last role at PepsiCo as the Chairman and CEO, PepsiCo India Manu was responsible for PepsiCo's beverage and foods business (including JVs) in India and South Asia, reporting to the President of AMEA.